1. Home
  2. BHVN vs LOB Comparison

BHVN vs LOB Comparison

Compare BHVN & LOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • LOB
  • Stock Information
  • Founded
  • BHVN 2013
  • LOB 2008
  • Country
  • BHVN United States
  • LOB United States
  • Employees
  • BHVN N/A
  • LOB N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • LOB Major Banks
  • Sector
  • BHVN Health Care
  • LOB Finance
  • Exchange
  • BHVN Nasdaq
  • LOB Nasdaq
  • Market Cap
  • BHVN 1.7B
  • LOB 1.7B
  • IPO Year
  • BHVN 2017
  • LOB 2015
  • Fundamental
  • Price
  • BHVN $15.63
  • LOB $35.86
  • Analyst Decision
  • BHVN Strong Buy
  • LOB Buy
  • Analyst Count
  • BHVN 14
  • LOB 4
  • Target Price
  • BHVN $49.23
  • LOB $43.75
  • AVG Volume (30 Days)
  • BHVN 2.4M
  • LOB 284.3K
  • Earning Date
  • BHVN 11-11-2025
  • LOB 10-22-2025
  • Dividend Yield
  • BHVN N/A
  • LOB 0.33%
  • EPS Growth
  • BHVN N/A
  • LOB N/A
  • EPS
  • BHVN N/A
  • LOB 1.21
  • Revenue
  • BHVN N/A
  • LOB $406,003,000.00
  • Revenue This Year
  • BHVN N/A
  • LOB $43.85
  • Revenue Next Year
  • BHVN $2,195.07
  • LOB $11.42
  • P/E Ratio
  • BHVN N/A
  • LOB $29.54
  • Revenue Growth
  • BHVN N/A
  • LOB N/A
  • 52 Week Low
  • BHVN $12.79
  • LOB $22.68
  • 52 Week High
  • BHVN $55.70
  • LOB $50.30
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 51.87
  • LOB 47.06
  • Support Level
  • BHVN $14.32
  • LOB $34.32
  • Resistance Level
  • BHVN $16.24
  • LOB $35.99
  • Average True Range (ATR)
  • BHVN 0.82
  • LOB 0.85
  • MACD
  • BHVN 0.11
  • LOB -0.18
  • Stochastic Oscillator
  • BHVN 60.92
  • LOB 35.56

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

Share on Social Networks: